Estratest-HS

contains 0.625 mg esterified estrogen & 1.25 mg of methyltestosterone; no other info avail 12/93

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Drug Overdose 09/01/1997 - "Reports of cancer, cardiovascular disease, thromboembolic phenomena, and hepatic dysfunction were few and were assessed as not related to treatment with Estratest or Estratest HS; reports of drug overdose, drug-drug interaction, and birth defects were rare (4 of 863 events; 0.5%). "
2.	Neoplasms (Cancer) 09/01/1997 - "Reports of cancer, cardiovascular disease, thromboembolic phenomena, and hepatic dysfunction were few and were assessed as not related to treatment with Estratest or Estratest HS; reports of drug overdose, drug-drug interaction, and birth defects were rare (4 of 863 events; 0.5%). "
3.	Cardiovascular Diseases (Cardiovascular Disease) 09/01/1997 - "Reports of cancer, cardiovascular disease, thromboembolic phenomena, and hepatic dysfunction were few and were assessed as not related to treatment with Estratest or Estratest HS; reports of drug overdose, drug-drug interaction, and birth defects were rare (4 of 863 events; 0.5%). "
4.	Congenital Abnormalities (Deformity) 09/01/1997 - "Reports of cancer, cardiovascular disease, thromboembolic phenomena, and hepatic dysfunction were few and were assessed as not related to treatment with Estratest or Estratest HS; reports of drug overdose, drug-drug interaction, and birth defects were rare (4 of 863 events; 0.5%). "